Together, these studies indicate that DNMT expression and activity, as well as global DNAm, are found increased in affected neural tissues from ALS patients and cellular and animal models of the disease, in which they likely reflect ongoing neurodegeneration. This evidence concerns the gene DNMT1 and amyotrophic lateral sclerosis.